Back to WA Wealthspire Advisors, LLC
FENC
Showing 0 of 5 quarters
Position history for WAWealthspire Advisors, LLC's holdings in FENNEC PHARMACEUTICALS INC
No. Wealthspire Advisors exited its FENC (Fennec Pharmaceuticals) position in Q4 2022. Its Q3 2022 13F listed 25,000 shares worth $202,000. Wealthspire Advisors first reported FENC in Q4 2021 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.